| Chemical Market Reporter |
| June 28, 1999 |
| Phasex Riding New Wave of SCF As Technology Awareness Grows. |
| Author/s: Clay Boswell |
| THE PROCESS CHEMICAL
industry is at a turning point in its relationship to supercritical fluids
(SCF), says Val Krukonis, president of Phasex Corporation, a Lawrence,
Mass., company specializing in SCF developmental work and toll processing. SCF has been used since
the late 1970s for the large-scale decaffeination of coffee and tea
and the extraction of flavors from hops and other natural sources. But
Dupont's recent announcement that it will construct a $40 million pilot
plant to explore the commercial feasibility of Teflon manufacture in
supercritical CO2 reflects a growing awareness of the technology's
broader applicability. Supercritical fluids are gases that have
been heated above their critical temperature and compressed. The
resulting fluid, which is not a true liquid, has a dissolving power that
is pressure-dependent. This property can be used for the extraction,
fractionation, or purification of complex chemical mixtures based on the
differential solubility of their components. Environmental friendliness is a major driver
in SCF, but Phasex has always had a different emphasis, says Mr. Krukonis.
Rather than sell SCF for what it doesn't do, Phasex sells SCF for what
it can do- especially to improve an existing product or produce a product
that cannot be achieved by any other technology. One example he offers is the formation of
nanoparticles of the anticancer agent paclitaxel. Extracted from the yew
tree, it must be administered intravenously in a hospital setting due
its large particle size. Precipitation from SCF, however, allows
for the careful control of particle size to yield uniform nanoparticles
that can be injected intramuscularly at a doctor's office. The same principle can be applied to many
other drugs, and Phasex is working with a Montreal company, RTP Pharma,
on the production of nanoparticles of hydrophobic drugs. Another example is the purification of a
polymer used in a medical device. The polymer had an impurity
deleterious to the body. "Using SCF, we process tens of
thousands of pounds of this polymer to remove the impurity, which is
present at only one-tenth of one percent of the total weight," says
Mr. Krukonis. Phasex has also used SCF for many other
applications that benefit from selective extraction, fractionation,
ultra-fine particle formation or surface modification. It is even
possible to run reactions in SCF. |
Copyright 1999 Schnell Publishing Company, Inc. in association with The Gale Group and LookSmart.